glp-1 deficiency Glucagon-like peptide 1 (GLP-1) GLP-1 Medications: Everything You Need

Anti-inflammatory effects of GLP-1 medicines independent of weight loss Several GLP-1 medicines, including semaglutide, liraglutide, and exenatide, reduce plasma levels of C-reactive protein (CRP), a surrogate of systemic inflammation, in people with obesity or T2D

This may occur due to factors such as dose level, calorie intake, metabolic adaptation, or reduced physical activity

The initial dose was 0.25 mg/week for four weeks, followed by 0.5 mg/week, with up-titration to 1.0 mg/week based on glucose control and tolerability

Understanding how caffeine interacts with your GLP-1 medication helps you maintain both your weight loss progress and quality of life

Breaks in semaglutide cold chain managementwhether due to logistical mishaps, improper storage at pharmacies, or mishandling by end-userspose significant risks to the efficacy of these therapies

Nunn E, Jaiswal N, Gavin M, et al